Searched for
MERCK SHARES
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leakModerna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline era...- US targets $500 billion India trade in 3 years, up from record $240 billion, Sergio Gor saysThe United States plans to increase bilateral trade with India to over USD 500 billion in three years. This trade target comes after reachi...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Domestic demand, labour supply give India structural advantage in semiconductor push: Bain & CoIndia's strong domestic demand and demographic dividend give it an advantage in the global semiconductor race, but access to core technolog...
- PM Modi asks semiconductor CEOs to step up industry participation in next phase of India’s growthPrime Minister Narendra Modi urged India to lead in emerging technologies. He assured industry leaders of a predictable and responsive poli...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
- US stocks today: US stocks end near flat as hot inflation data clouds Fed rate outlookWall Street ended nearly flat as hotter-than-expected US inflation complicated the Federal Reserve’s interest-rate outlook. Investors turne...
- US lawmakers question Health Secretary Kennedy on vaccine settlement disclosuresUS senators are questioning Health Secretary Robert F. Kennedy Jr.'s explanation regarding his financial stake. His recent statements confl...
- US stocks today: US stocks close higher on tech rebound as Nvidia earnings gain focusUS stocks closed higher as technology and semiconductor shares recovered ahead of Nvidia's earnings. Lower oil prices and Treasury yields o...
- Global Market: China, Hong Kong stocks rebound as healthcare and tech shares rallyChina and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. F...
- US stocks: US market rises as yields ease, Moderna lifts healthcare stocksUS stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despit...
- Moderna shares soar 159% in a day after cancer vaccine succeeds in late-stage trialModerna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, redu...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities extended losses for a seventh session as rising oil prices and US-Iran tensions heightened risk aversion. Nifty fell to 24,...
- US stocks: US market regains ground as bond yields ease; healthcare stocks rallyMajor stock indexes recovered on Wednesday after a prior day's decline. Moderna shares surged significantly following positive cancer thera...
- CCI approves P&G's stake acquisition in MerckThe global deal is for about 3.4 billion euro in cash.
- Buy Merck with a target of Rs 1,000: Mitesh Thacker"Merck is a 'BUY' call with a target of Rs 1,000 and a stop loss of Rs 655."
- Pfizer, Merck to cut 1,700 jobs following mergersCombined, Pfizer and Wyeth plan to cut about 20,000 jobs, or 15 percent of their combined staff in the future. Top 10 Paymasters | Intervie...
- Merck to acquire biotech firm Serono for $13.3 bnGerman drugmaker Merck unveiled a surprise 16.6-bn-Swiss franc ($13.3 bn) deal to buy Swiss biotech firm Serono on Thursday, creating a new...
- Merck hikes Schering stake, threatens BayerGerman drugs and chemicals group Merck has raised its holding in rival Schering to just over 10%, threatening a planned takeover of Scherin...
Load More
